Vaccines

intradermal-delivery-of-polio-vaccines-may-dramatically-reduce-the-dose-required-for-vaccination-by-several-folds-thereby-reducing-the-cost-and-increasing-the-affordability

Study compares efficacy of oral, injectable polio vaccines

  • US
  • |
  • News

Singapore: NanoPass Technologies, a pioneer in intradermal vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase III trial of polio vaccine in infants in South... Read more

has-the-life-science-industry-learnt-from-previous-flu-outbreaks

How well is the industry prepared to fight H7N9 bird...


  • China
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 0 Comment

During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two months... Read more

dr-krishna-ella-chairman-and-managing-director-bharat-biotech-and-member-of-the-scientific-advisory-committee-to-the-prime-minister-india

Everyone thought my $1 vaccine shot idea was crazy...


  • India
  • |
  • Opinion
  • |
  • By Dr Krishna Ella
  • |
  • 0 Comment

My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and wellness.... Read more

mou1

ICAR transfers vaccine technology to Sanvita

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: The Indian Council of Agricultural Research signed a memorandum of understanding (MoU) with Sanvita Biotechnologies of Hyderabad... Read more

vaccine-production

Medicago achieves milestone in VLP vaccine production

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing... Read more

new-hope-for-brain-tumor-white-blood-cell-vaccine

Potential new tool against aggressive brain cancer

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Researchers at the Northwestern Brain Tumor Institute (NBTI) are trying to understand if a vaccine made from patient's own blood... Read more

dengue-vaccine

Sanofi dengue vaccine demonstrates proof of efficacy

  • Thailand
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: The tetravalent dengue vaccine candidate of Sanofi Pasteur, the vaccines division of Sanofi, demonstrated proof of efficacy against... Read more

vaccine-non-traditional

The unconventional side of vaccines

  • Australia
  • |
  • Opinion
  • |
  • By Nikolai Petrovsky
  • |
  • 0 Comment

When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in recent years the uses... Read more

vaccine-malaria-india

Novavax, CPL Biologicals, ICGEB join hands for malaria research

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: Novavax, CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), have formed a... Read more

vaccine-research-biodiem

BioDiem to create new non-influenza vaccines

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement with The Royal Melbourne... Read more

vaccine-research

A push to accelerate next-gen immunogen design

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

According to the International AIDS Vaccine Initiative (IAVI), in September 2009, scientists reported isolation of a pair of potent and... Read more

nasal-vaccine-drug-delivery

Intra-nasal vaccine: Answer to avian influenza threat

  • Japan
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 1 Comment

There is a fear that avian H5N1 virus could cause a pandemic of new influenza in humans without any warning. To prevent the contagious infectious... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X